|
Volumn 146, Issue 5, 2002, Pages 872-876
|
Long-term prognosis of patients treated for erythema migrans in France
|
Author keywords
Amoxycillin; Doxycycline; Erythema migrans; Lyme borreliosis; Prognosis
|
Indexed keywords
AMOXICILLIN;
TETRACYCLINE DERIVATIVE;
ADOLESCENT;
ADULT;
AGED;
ARTHRALGIA;
ARTICLE;
BORRELIA BURGDORFERI;
CLINICAL EXAMINATION;
CLINICAL FEATURE;
CONTROLLED STUDY;
DISEASE COURSE;
ENZYME IMMUNOASSAY;
ERYTHEMA CHRONICUM MIGRANS;
FEMALE;
FOLLOW UP;
FRANCE;
HUMAN;
INTERVIEW;
LONG TERM CARE;
LYME DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL ASSESSMENT;
MYALGIA;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
SCHOOL CHILD;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
AMOXICILLIN;
ANTI-BACTERIAL AGENTS;
BORRELIA BURGDORFERI;
CHILD;
ERYTHEMA CHRONICUM MIGRANS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
PENICILLINS;
PROGNOSIS;
PROSPECTIVE STUDIES;
TETRACYCLINES;
TREATMENT OUTCOME;
|
EID: 0036098804
PISSN: 00070963
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2133.2002.04628.x Document Type: Article |
Times cited : (36)
|
References (25)
|